Stem Cells Could be Used for Personalized Cancer Treatment

	Tweet

Using cancer cells from an ovarian cancer patient and human embryonic stem cells, Israeli researchers have created a cancerous tumor in a mouse that mimics the way the tumor would develop in the patient’s body. The result is a pre-clinical experimental model for cancer research that could facilitate the development of personalized cancer therapies. The findings are published in the January 2009 online version of Clinical Cancer Research.

Until now, there have been very few pre-clinical experimental models in which cancer cells from an actual patient could be successfully grown in such a manner, say the researchers from the Technion-Israel Institute of Technology’s Rappaport Faculty of Medicine and Rambam Medical Center.

The team, led by the Technion’s Prof. Karl Skorecki and Dr. Maty Tzukerman, created the model by introducing a human patient’s ovarian cancer stem cells into a teratoma (a growth made up of a mixture of human tissues, including blood vessels, fat tissue and connective tissue) in a mouse. The teratoma in the mouse was derived from human embryonic stem cells.

“Growing cancer stem cells from the patient in a way that mirrors their growth in the human body could allow clinicians to check the sensitivity of a particular tumor to different treatments,” explains Dr. Tzukerman. “This ability could provide clinicians with ways to customize cancer treatments for each individual patient.”

Skorecki and Tzukerman supervised Technion graduate student Ehood Katz, who from one patient isolated and characterized six different subpopulations of ovarian cancer cells, each of which was placed into a different teratoma. The cells from that one patient reflected the variety of characteristics of ovarian cancer in different patients, and also exposed the presence of “master cells” – the progenitors responsible for the recurrence and regrowth of cancer, even after derivative “daughter” cells are killed off by chemotherapy. These master cells in ovarian and other cancers appear to be the most important targets in anti-cancer treatments.

The research findings also emphasize that the choice of the environment in which to establish the experimental platform to grow cells and establish the tumor model is crucial. “The choice of the right milieu is critical in order to expose a subset of the most relevant cancer cells to study and target, and which otherwise might evade such study,” says Skorecki.

The Technion-Israel Institute of Technology is Israel’s leading science and technology university. Home to the country’s winners of the Nobel Prize in science, it commands a worldwide reputation for its pioneering work in nanotechnology, computer science, biotechnology, water-resource management, materials engineering, aerospace and medicine. The majority of the founders and managers of Israel’s high-tech companies are alumni. Based in New York City, the American Technion Society (ATS) is the leading American organization supporting higher education in Israel, with 22 offices around the country.

Source: American Technion Society

RELATED STORIES:
An experiment in earlier detection of ovarian cancer   Cancer stem cells recruit normal stem cells to fuel ovarian cancer, U-M study finds   Novel Study Using Reoviruses Against Ovarian Cancer Pushes Forward   Researchers identify genes that may help in ovarian cancer diagnosis and prognosis   Platypus Link to Ovarian Cancer   Faulty proteins may prove significant in identifying new treatments for ovarian cancer   Early periods may reduce ovarian cancer survival   Obesity may raise risk of ovarian cancer   Extracellular protein sensitizes ovarian cancer cells to chemotherapy   TG2 identified as potential therapeutic target in chemo-resistant ovarian cancer   Clues to Ovarian Cancer’s Deadly Secrets   Women often opt to surgically remove their breasts, ovaries to reduce cancer risk   Abdominal chemotherapy boosts survival in ovarian cancer patients   Two gene mutations mark deadly ovarian cancer   Folate receptors may serve as a front door to ovarian cancer treatment   Finding ovarian cancer fast may not help survival   Removal of Ovaries Decreases Cancer Risk for Women at High-Risk   OHSU Primate Center’s Ovarian Cancer Finding May be a “Win-Win” for At-Risk Women Who Wish to Have a Family   Addition of dasatinib to standard chemo cocktail may enhance effect in certain ovarian cancers   Ovulation induction linked with cancer risk   Study Reveals Why Certain Ovarian Cancers Develop Resistance to Platinum-based Chemotherapy   Short-term OC use cuts ovarian cancer risk

Comments

[ + Post Your Own ]

Now you're in the public comment zone. What follows is not Armenian Medical Network's stuff; it comes from other people and we don't vouch for it. A reminder: By using this Web site you agree to accept our Terms of Service. Click here to read the Rules of Engagement.

There are no comments for this entry yet. [ + Comment here + ]